IOL CHEMICALS & PHARM. | HINDUSTAN BIOSCIE | IOL CHEMICALS & PHARM./ HINDUSTAN BIOSCIE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 296.5 | 4.5% | View Chart |
P/BV | x | 1.5 | 11.1 | 13.5% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. HINDUSTAN BIOSCIE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
HINDUSTAN BIOSCIE Mar-23 |
IOL CHEMICALS & PHARM./ HINDUSTAN BIOSCIE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 6 | 9,583.9% | |
Low | Rs | 272 | 3 | 8,427.2% | |
Sales per share (Unadj.) | Rs | 377.6 | 0.9 | 41,982.5% | |
Earnings per share (Unadj.) | Rs | 23.7 | 0 | -60,730.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 0 | -92,431.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 0.7 | 35,238.1% | |
Shares outstanding (eoy) | m | 58.71 | 10.25 | 572.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 4.9 | 21.8% | |
Avg P/E ratio | x | 17.1 | -111.7 | -15.3% | |
P/CF ratio (eoy) | x | 12.8 | -130.2 | -9.8% | |
Price / Book Value ratio | x | 1.6 | 6.1 | 26.0% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 45 | 52,463.0% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 2 | 93,972.1% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 9 | 240,467.5% | |
Other income | Rs m | 256 | 0 | - | |
Total revenues | Rs m | 22,427 | 9 | 243,245.1% | |
Gross profit | Rs m | 2,257 | 0 | -805,964.3% | |
Depreciation | Rs m | 462 | 0 | 769,333.3% | |
Interest | Rs m | 165 | 0 | 411,750.0% | |
Profit before tax | Rs m | 1,887 | 0 | -496,447.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | 1,650,333.3% | |
Profit after tax | Rs m | 1,391 | 0 | -347,850.0% | |
Gross profit margin | % | 10.2 | -3.1 | -332.9% | |
Effective tax rate | % | 26.2 | -6.6 | -398.9% | |
Net profit margin | % | 6.3 | -4.4 | -143.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 9 | 112,401.2% | |
Current liabilities | Rs m | 5,025 | 14 | 35,438.6% | |
Net working cap to sales | % | 20.9 | -60.6 | -34.6% | |
Current ratio | x | 1.9 | 0.6 | 317.2% | |
Inventory Days | Days | 43 | 946 | 4.6% | |
Debtors Days | Days | 8 | 179,564,165 | 0.0% | |
Net fixed assets | Rs m | 11,017 | 24 | 45,451.3% | |
Share capital | Rs m | 587 | 21 | 2,863.9% | |
"Free" reserves | Rs m | 14,490 | -13 | -111,120.4% | |
Net worth | Rs m | 15,077 | 7 | 201,836.7% | |
Long term debt | Rs m | 0 | 11 | 0.0% | |
Total assets | Rs m | 20,684 | 33 | 62,983.9% | |
Interest coverage | x | 12.5 | -8.5 | -146.5% | |
Debt to equity ratio | x | 0 | 1.5 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.3 | 381.8% | |
Return on assets | % | 7.5 | -1.1 | -679.7% | |
Return on equity | % | 9.2 | -5.4 | -170.4% | |
Return on capital | % | 13.6 | -1.8 | -751.2% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 6 | 101,023.9% | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 6 | -2,073.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -1 | -244,540.0% | |
From Investments | Rs m | -1,200 | NA | - | |
From Financial Activity | Rs m | -41 | 1 | -8,220.0% | |
Net Cashflow | Rs m | -18 | 0 | - |
Indian Promoters | % | 48.2 | 12.2 | 395.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 87.8 | 59.0% | |
Shareholders | 130,003 | 10,921 | 1,190.4% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | HINDUSTAN BIOSCIE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.81% | 0.00% | -0.28% |
1-Month | -4.15% | 1.25% | 2.32% |
1-Year | -3.73% | -3.23% | 50.06% |
3-Year CAGR | -11.90% | 44.76% | 14.27% |
5-Year CAGR | 15.44% | 53.84% | 19.23% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the HINDUSTAN BIOSCIE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of HINDUSTAN BIOSCIE the stake stands at 12.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of HINDUSTAN BIOSCIE.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
HINDUSTAN BIOSCIE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of HINDUSTAN BIOSCIE.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.